Literature DB >> 24639359

Hepatic stellate cells orchestrate clearance of necrotic cells in a hypoxia-inducible factor-1α-dependent manner by modulating macrophage phenotype in mice.

Akie Mochizuki1, Aaron Pace1, Cheryl E Rockwell1, Katherine J Roth1, Aaron Chow1, Kate M O'Brien1, Ryan Albee1, Kara Kelly1, Keara Towery2, James P Luyendyk2, Bryan L Copple1.   

Abstract

Hypoxia-inducible factor-1α (HIF-1α) is activated in hepatic stellate cells (HSCs) by hypoxia and regulates genes important for tissue repair. Whether HIF-1α is activated in HSCs after acute injury and contributes to liver regeneration, however, is not known. To investigate this, mice were generated with reduced levels of HIF-1α in HSCs by crossing HIF-1α floxed mice with mice that express Cre recombinase under control of the glial fibrillary acidic protein (GFAP) promoter (i.e., HIF-1α-GFAP Cre+ mice). These mice and control mice (i.e., HIF-1α-GFAP Cre- mice) were treated with a single dose of carbon tetrachloride, and liver injury and repair were assessed. After carbon tetrachloride, HIF-1α was activated in HSCs. Although liver injury was not different between the two strains of mice, during resolution of injury, clearance of necrotic cells was decreased in HIF-1α-GFAP Cre+ mice. In these mice, the persistence of necrotic cells stimulated a fibrotic response characterized by extensive collagen deposition. Hepatic accumulation of macrophages, which clear necrotic cells from the liver after carbon tetrachloride, was not affected by HIF-1α deletion in HSCs. Conversion of macrophages to M1-like, proinflammatory macrophages, which have increased phagocytic activity, however, was reduced in HIF-1α-GFAP Cre+ mice as indicated by a decrease in proinflammatory cytokines and a decrease in the percentage of Gr1(hi) macrophages. Collectively, these studies have identified a novel function for HSCs and HIF-1α in orchestrating the clearance of necrotic cells from the liver and demonstrated a key role for HSCs in modulating macrophage phenotype during acute liver injury.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24639359      PMCID: PMC4538924          DOI: 10.4049/jimmunol.1303195

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production.

Authors:  Michal Safran; William Y Kim; Fionnuala O'Connell; Lee Flippin; Volkmar Günzler; James W Horner; Ronald A Depinho; William G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

2.  Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis.

Authors:  Norihiko Takeda; Ellen L O'Dea; Andrew Doedens; Jung-whan Kim; Alexander Weidemann; Christian Stockmann; Masataka Asagiri; M Celeste Simon; Alexander Hoffmann; Randall S Johnson
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

3.  Plasminogen activators direct reorganization of the liver lobule after acute injury.

Authors:  J A Bezerra; A R Currier; H Melin-Aldana; G Sabla; T H Bugge; K W Kombrinck; J L Degen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  Early growth response factor-1 is critical for cholestatic liver injury.

Authors:  Nam Deuk Kim; Jeon-Ok Moon; Angela L Slitt; Bryan L Copple
Journal:  Toxicol Sci       Date:  2006-01-19       Impact factor: 4.849

7.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

8.  Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice.

Authors:  Jeon-Ok Moon; Timothy P Welch; Frank J Gonzalez; Bryan L Copple
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-08       Impact factor: 4.052

9.  A novel mouse model of depletion of stellate cells clarifies their role in ischemia/reperfusion- and endotoxin-induced acute liver injury.

Authors:  Rachel K Stewart; Anil Dangi; Chao Huang; Noriko Murase; Shoko Kimura; Donna B Stolz; Gregory C Wilson; Alex B Lentsch; Chandrashekhar R Gandhi
Journal:  J Hepatol       Date:  2013-09-20       Impact factor: 25.083

10.  Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes.

Authors:  Bryan L Copple; Juan J Bustamante; Timothy P Welch; Nam Deuk Kim; Jeon-Ok Moon
Journal:  Liver Int       Date:  2009-03-19       Impact factor: 5.828

View more
  22 in total

1.  Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells.

Authors:  Kang Ho Kim; Jae Man Lee; Ying Zhou; Sanjiv Harpavat; David D Moore
Journal:  Mol Endocrinol       Date:  2016-06-29

2.  Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice.

Authors:  Satoko Arai; Kento Kitada; Tomoko Yamazaki; Ryosuke Takai; Xizhong Zhang; Yoji Tsugawa; Ryoichi Sugisawa; Ayaka Matsumoto; Mayumi Mori; Yasunori Yoshihara; Kent Doi; Natsumi Maehara; Shunsuke Kusunoki; Akiko Takahata; Eisei Noiri; Yusuke Suzuki; Naoki Yahagi; Akira Nishiyama; Lakshman Gunaratnam; Tomoko Takano; Toru Miyazaki
Journal:  Nat Med       Date:  2016-01-04       Impact factor: 53.440

3.  Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.

Authors:  Kuei-Chuan Lee; Wei-Fan Hsu; Yun-Cheng Hsieh; Che-Chang Chan; Ying-Ying Yang; Yi-Hsiang Huang; Ming-Chih Hou; Han-Chieh Lin
Journal:  Dig Dis Sci       Date:  2018-10-04       Impact factor: 3.199

Review 4.  AIM associated with the IgM pentamer: attackers on stand-by at aircraft carrier.

Authors:  Toru Miyazaki; Tomoko Yamazaki; Ryoichi Sugisawa; M Eric Gershwin; Satoko Arai
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 5.  Pathogenesis of Kupffer Cells in Cholestatic Liver Injury.

Authors:  Keisaku Sato; Chad Hall; Shannon Glaser; Heather Francis; Fanyin Meng; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2016-07-22       Impact factor: 4.307

Review 6.  Hypoxia-inducible factors and innate immunity in liver cancer.

Authors:  Vincent Wai-Hin Yuen; Carmen Chak-Lui Wong
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 7.  Hepatic Ischemia/Reperfusion: Mechanisms of Tissue Injury, Repair, and Regeneration.

Authors:  Takanori Konishi; Alex B Lentsch
Journal:  Gene Expr       Date:  2017-09-11

8.  Fibrotic liver has prompt recovery after ischemia-reperfusion injury.

Authors:  Takanori Konishi; Rebecca M Schuster; Holly S Goetzman; Charles C Caldwell; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-21       Impact factor: 4.052

9.  Dichotomous Role of Plasmin in Regulation of Macrophage Function after Acetaminophen Overdose.

Authors:  Katherine Roth; Jenna Strickland; Nikita Joshi; Meihong Deng; Rebekah C Kennedy; Cheryl E Rockwell; James P Luyendyk; Timothy R Billiar; Bryan L Copple
Journal:  Am J Pathol       Date:  2019-08-02       Impact factor: 4.307

Review 10.  Genetically Encoded Tools for Research of Cell Signaling and Metabolism under Brain Hypoxia.

Authors:  Alexander I Kostyuk; Aleksandra D Kokova; Oleg V Podgorny; Ilya V Kelmanson; Elena S Fetisova; Vsevolod V Belousov; Dmitry S Bilan
Journal:  Antioxidants (Basel)       Date:  2020-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.